Back to search
Diffuse Astrocytoma, IDH-Wildtype
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Diffuse Astrocytoma, IDH-Wildtype trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Diffuse Astrocytoma, IDH-Wildtype trials you may qualify forThis multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 alo…
This phase II trial studies how well temozolomide and radiation therapy work in treating patients with IDH wildtype historically lower grade gliomas or non-hist…
The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type…
This phase II trial studies the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioma that has come back (recurrent) and car…
This phase I trial tests the safety, side effects, and best dose of triapine in combination with radiation therapy in treating patients with glioblastoma or ast…